FMRFamide-Like Peptides (FLPs) Enhance Voltage-Gated Calcium Currents to Elicit Muscle Contraction in the Human Parasite Schistosoma mansoni by Novozhilova, Ekaterina et al.
Biomedical Sciences Publications Biomedical Sciences
8-10-2010
FMRFamide-Like Peptides (FLPs) Enhance
Voltage-Gated Calcium Currents to Elicit Muscle
Contraction in the Human Parasite Schistosoma
mansoni
Ekaterina Novozhilova
Iowa State University
Michael J. Kimber
Iowa State University, michaelk@iastate.edu
Hai Qian
Iowa State University
Paul McVeigh
Queen's University Belfast
Alan P. Robertson
Iowa State University, alanr@iastate.edu
See next page for additional authors
Follow this and additional works at: http://lib.dr.iastate.edu/bms_pubs
Part of the Neuroscience and Neurobiology Commons, and the Parasitic Diseases Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/
bms_pubs/18. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Biomedical Sciences at Iowa State University Digital Repository. It has been accepted for
inclusion in Biomedical Sciences Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please
contact digirep@iastate.edu.
FMRFamide-Like Peptides (FLPs) Enhance Voltage-Gated Calcium
Currents to Elicit Muscle Contraction in the Human Parasite Schistosoma
mansoni
Abstract
Schistosomes are amongst the most important and neglected pathogens in the world, and schistosomiasis
control relies almost exclusively on a single drug. The neuromuscular system of schistosomes is fertile ground
for therapeutic intervention, yet the details of physiological events involved in neuromuscular function remain
largely unknown. Short amidated neuropeptides, FMRFamide-like peptides (FLPs), are distributed
abundantly throughout the nervous system of every flatworm examined and they produce potent
myoexcitation. Our goal here was to determine the mechanism by which FLPs elicit contractions of
schistosome muscle fibers. Contraction studies showed that the FLP Tyr-Ile-Arg-Phe-amide (YIRFamide)
contracts the muscle fibers through a mechanism that requires Ca2+ influx through sarcolemmal voltage
operated Ca2+ channels (VOCCs), as the contractions are inhibited by classical VOCC blockers nicardipine,
verapamil and methoxyverapamil. Whole-cell patch-clamp experiments revealed that inward currents through
VOCCs are significantly and reversibly enhanced by the application of 1 µM YIRFamide; the sustained inward
currents were increased to 190% of controls and the peak currents were increased to 180%. In order to
examine the biochemical link between the FLP receptor and the VOCCs, PKC inhibitors calphostin C, RO
31–8220 and chelerythrine were tested and all produced concentration dependent block of the contractions
elicited by 1 µM YIRFamide. Taken together, the data show that FLPs elicit contractions by enhancing Ca2+
influx through VOCC currents using a PKC-dependent pathway.
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Abstract
Schistosomes are amongst the most important and neglected pathogens in the world, and schistosomiasis control relies
almost exclusively on a single drug. The neuromuscular system of schistosomes is fertile ground for therapeutic
intervention, yet the details of physiological events involved in neuromuscular function remain largely unknown. Short
amidated neuropeptides, FMRFamide-like peptides (FLPs), are distributed abundantly throughout the nervous system of
every flatworm examined and they produce potent myoexcitation. Our goal here was to determine the mechanism by
which FLPs elicit contractions of schistosome muscle fibers. Contraction studies showed that the FLP Tyr-Ile-Arg-Phe-amide
(YIRFamide) contracts the muscle fibers through a mechanism that requires Ca2+ influx through sarcolemmal voltage
operated Ca2+ channels (VOCCs), as the contractions are inhibited by classical VOCC blockers nicardipine, verapamil and
methoxyverapamil. Whole-cell patch-clamp experiments revealed that inward currents through VOCCs are significantly and
reversibly enhanced by the application of 1 mM YIRFamide; the sustained inward currents were increased to 190% of
controls and the peak currents were increased to 180%. In order to examine the biochemical link between the FLP receptor
and the VOCCs, PKC inhibitors calphostin C, RO 31–8220 and chelerythrine were tested and all produced concentration
dependent block of the contractions elicited by 1 mM YIRFamide. Taken together, the data show that FLPs elicit contractions
by enhancing Ca2+ influx through VOCC currents using a PKC-dependent pathway.
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Introduction
Schistosomes continue to inflict widespread suffering, infecting
over 200 million worldwide, yet a proportional lack of scientific
attention leaves schistosomiasis as one of the most prevalent
neglected tropical diseases [1,2]. Significant advances in schisto-
somiasis control have been achieved in the past few years, due
primarily to well-organized control programmes that include
aggressive chemotherapy [3,4]. While these programmes produce
unquestionable public health benefit, their assertive use of
praziquantel raises concern about the potential emergence of
resistance to the drug, which is the only antischistosomal available
in most of the world. The schistosomiasis community has
recognized the urgent need for new chemotherapeutic agents
[5,6].
Current approaches to drug discovery are significantly hindered
by large gaps in our understanding of the basic biology of
schistosomes at a molecular level. For example, even though most
anthelmintic drugs have effects on the neuromuscular systems of
worms, very little is known about the specifics of neuromuscular
anatomy and physiology, nor the mechanisms involved in
neuromuscular control.
The neuropeptidergic system in parasitic flatworms is known to
be remarkably rich [7,8]. Flatworm Phe-Met-Arg-Phe-amide
(FMRFamide)-like peptides (FLPs), one particular group of Arg-
Phe-amides (RFamides), are known to play a central role in
parasite neuromuscular biology; they are widespread throughout
the nervous system of every flatworm examined, and they produce
potent excitation of flatworm muscle [9,10,11,12,13,14]. The
RFamides present in vertebrates are structurally dissimilar to those
in helminths, suggesting that flatworm FLPs and associated
signaling molecules represent opportune targets for therapeutic
control. Our objective here was to discover the mechanism by
which these FLPs induce contraction of schistosome muscle fibers.
Materials and Methods
Parasites and Muscle Fiber Dispersion
The studies here are focused on muscle fibers dispersed from adult
Schistosoma mansoni. The fibers are obtained from adult worms recovered
45-60 days post-infection from the portal and mesenteric veins of
female mice supplied by the Biomedical Research Institute, Rockville,
MD USA [15]. Iowa State University’s Institutional Animal Care and
Use Committee (IACUC) approved the role of the mice.
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The incubation medium used for the fibers was based on a
modified Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-
Aldrich, USA) which was diluted to 67% of normal concentration
and to which were added the following: 2.2 mM CaCl2, 2.7 mM
MgSO4, 0.04 mM Na2HPO4, 61 mM glucose, 1.0 mM dithio-
threitol, 10 mM serotonin, 1% gentamicin solution (Roche Applied
Science, USA), 15 mM 4-(2-hydroxyethyl)-1-piperazine ethane-
sulfonic acid (HEPES) (pH 7.4). The dispersion medium was this
same medium to which was further added 1 mM ethyleneglycol-
bis-(b-aminoethyl ether) N, N, N’ N’-tetraacetic acid (EGTA),
1 mM ethylenediamine tetraacetic acid (EDTA), and 0.1% bovine
serum albumin.
Briefly, live worms (25–30 pairs) were rinsed four times with
the dispersion medium described above and then chopped
approximately 35–40 times with a razor blade. Resultant worm
pieces were rinsed four times, then incubated for 30 min at
37uC on a shaker table with the dispersion medium with added
papain (1 mg/ml, Roche Applied Science, USA). After the
enzymatic medium was removed, the worm pieces were rinsed
twice with the enzyme free dispersion medium, then incubated
for an additional 10 min. After a final rinse, worm pieces were
mechanically disrupted by forcing them back and forth
through the orifice of a Pasteur pipet, creating a suspension
of some partially digested worm pieces and some dispersed
cells and muscle fibers (Figure 1). This suspension was plated
into plastic Petri dishes in the dispersion medium and was
allowed to settle for one hour in the cooler at 19uC. During this
hour of incubation, many dispersed muscle fibers partially
adhered to the bottom of the Petri dishes. More detailed
descriptions of these methods have been published [10,16]. For
both the contraction and the patch-clamp experiments, the
Petri dishes were warmed to 35uC for 15–30 min prior to
experimentation, and the experiments were performed in room
air with the temperature held at 35uC via a culture dish heater
and controller (DH-35 and TC-324B, Warner Instruments,
USA).
Author Summary
Schistosomiasis (bilharzia) is caused by infection with
trematodes of the genus Schistosoma. The disease afflicts
over 200 million people, with the bulk of the disease
burden focused in some of the world’s poorest countries.
Schistosomiasis control rests largely on chemotherapy
with a single drug, praziquantel, a precarious situation
calling for the discovery and development of new
antischistosomal agents. One hindrance to the discovery
of new drugs is a deficiency of knowledge regarding some
basic biological processes of these parasitic worms. Here,
we take significant steps toward the elucidation of
signaling and pathways involved in schistosome neuro-
muscular control, a central biological function with proven
vulnerability to chemotherapeutic intervention. Neuropep-
tides are known to be important in flatworm muscle
control and here we find that FMRFamide-like peptides act
to contract schistosome muscle by enhancing calcium
influx through voltage-operated calcium channels. We also
found that the receptor for the myoexcitatory neuropep-
tides uses a protein kinase C pathway to stimulate the
voltage-operated calcium channels. Understanding the
molecules involved in the neuromuscular physiology of
these worms helps to identify potentially useful targets for
a new generation of antischistosomal drugs.
Figure 1. Contractile muscle fibers can be dispersed from adult schistosomes. (A) A typical field from a dish of the dispersion described in
the methods. Amongst some debris and other cell types, there are a significant number of frayed muscle fibers which contract in response to the
application of exogenous stimuli. (B) One specific frayed muscle fiber is approached by a pipet loaded with 1 mM YIRFamide dissolved into the same
incubation medium in which the fiber is resting. (C) Pressure ejection of the YIRFamide onto the muscle fiber induces an abrupt contraction. For all
three pictures the scale bar is 25 mm.
doi:10.1371/journal.pntd.0000790.g001
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Contraction Studies
The contraction studies utilize these dispersed muscle fibers in
the DMEM-based incubation medium described above. Quiescent
fibers bathing in the incubation medium are individually perifused
with test media in order to examine the ability of those media to
elicit contraction. In a few instances, the incubation medium is
substituted for an ‘‘inorganic’’ version, primarily in an effort to
control precipitating interactions between various test agents and
the phosphates in the incubation medium.
Observations of individual muscle fiber contractions were
carried out using an inverted microscope (Nikon Eclipse TS 100)
attached to camera, video-recorder and a monitor. These test
media were pressure ejected through a pulled glass pipet onto
individual quiescent muscle fibers, and a fiber was considered to
have contracted if it shortened to less than 50% of its pretreatment
length in 20 s. These contractions are very rarely equivocal. For
each plate, 25–40 fibers were tested and the percentage of fibers
contracting for that plate represents n= 1. Each data point is given
as the mean 6 SEM for at least five plates tested on cell
preparations done on at least three different days.
Three different test media were applied to elicit contractions in
these experiments.
(1) The flatworm-derived neuropeptide Tyr-Ile-Arg-Phe-amide
(YIRFamide). Amongst the earliest discovered flatworm
neuropeptides was YIRFamide from Bdelloura candida, and it
was soon thereafter found to have potent myoexcitatory
action on a number of flatworm preparations including
schistosomes [9,10,11,12,14,17]. Similar neuropeptides (e.g.
GYIRFamide, RYIRFamide and YMRFamide) have also
been discovered in the phylum [8]. YIRFamide (Invitrogen,
USA) was dissolved in the standard incubation medium at
1 mM.
(2) A depolarizing extracellular medium with elevated [K+]. The
depolarizing medium is identical to the standard incubation
medium, except that the [K+] is raised from 5.4 mM to
25 mM, and the [K+] x [Cl2] product is kept constant by
substitution of some of the NaCl with Na-gluconate.
(3) Caffeine. Caffeine was dissolved at 1 mM in the standard
incubation medium [18].
Agents tested for their ability to block contractions were
introduced into the incubation medium 15 min prior to testing
with the contractile agents. Stock solutions for the water-soluble
test agents (1022 M) were prepared in water. Stock solutions for
the remaining blockers were prepared at the same concentration
in DMSO, with the exception of nicardipine, which was dissolved
in absolute ethanol. Due to light activation of calphostin C, stock
solutions and dilutions were made in dim light and protected from
light by wrapping containers in aluminum foil. All of these stock
solutions were further diluted in the incubation medium.
Patch-Clamp Experiments
The standard extracellular bathing solution for electrophysio-
logical recordings was (mM): NaCl 130; KCl 5.0; CaCl2 2.0;
glucose 10.0; MgCl2 1.0; HEPES 20.0 (pH 7.3). The incubation
medium in which the dispersed fibers were resting was exchanged
for this standard extracellular bathing solution about 10 min
before recording. A fiber targeted for recording inward currents
was then locally perifused with an extracellular recording solution
with elevated Ca2+ and Ba2+ in order to maximize the inward
currents, composed of (mM): HEPES 20.0; MgCl2 1.0; glucose
10.0; NaCl 112.0; KCl 5.0; CaCl2 2.0; BaCl2 15.0 (pH 7.3). The
electrode solution contained (mM): HEPES 10.0; MgCl2 2.0;
glucose 10.0; CsMethaneSulfonate 130.0; CsCl 20.0; EGTA 10.0
(pH 7.3). All solutions used for electrophysiology were filtered at
0.2 mm.
The application of the extracellular recording solution and the
drug-containing extracellular solutions utilized a SF-77B Perfusion
Fast-Step (Warner Instrument Corporation, USA) apparatus for
the rapid changes from control to drug-containing solutions and
subsequent return to control solution for washout. Syringes with
solutions were mounted approximately 14 inches over the
preparation to produce a gravity-fed flow rate of approximately
0.5 ml/min.
Whole-cell recordings were performed using Axopatch 200B
(Axon Instruments, USA) patch clamp amplifier. Experiments
were controlled and data recorded using pCLAMP software
(pCLAMP 8.0) and the Digidata 1320 analog-to-digital interface
(Axon Instruments, USA). Currents were amplified, low-pass
filtered at 1 kHz, digitized at 11.1 kHz and stored on a personal
computer.
Patch-clamp pipets were double-pulled from borosilicate glass
capillaries (outer diameter 1.2 mm, inner diameter 0.68 mm;
World Precision Instruments, USA) using the PC-10 Micropipette
Puller (Narishige, Japan). Since isolated S. mansoni fibers are
relatively small (15–20 mm), successful seals and whole-cell
configuration were obtained using patch electrodes with resistanc-
es that usually ranged from 15 to 20 MV. Because the voltage
operated inward currents from the dispersed S. mansoni muscle
fibers are also relatively small (less than 100 pA), series resistance
compensation was not usually used. Series resistances yielded after
whole-cell access were typically less than 50 MV, giving rise to an
error in command potential less than 5 mV for a 100 pA current.
High-resistance seals and whole cell access were obtained in
fibers constantly perifused with the extracellular recording
solution. Control fibers remained under the perifusion for the
length of the trial. In test groups after the inward current reached a
steady state (1.5 min after the start of the trial), the lines supplying
perifusion system were switched from control to drug-containing
bathing solution for 2.5 minutes followed by washout with control
solution.
For all of the pharmacology experiments on the inward
currents, the fibers were voltage-clamped at Vh of 270 mV and
depolarized to +20 mV for 200 ms twice every 30 sec. Leak and
capacity currents were assessed and subtracted online from test
currents using a P/2 protocol in pCLAMP software. All
subsequent data analysis employed averaged leak subtracted
current values.
Peak current values used corresponded to peak amplitudes
within first 50 ms of the 200 ms test pulse by 5 point smoothing.
The sustained current values corresponded to mean amplitudes
within the last 50 ms of the 200 ms test pulse. For the plotting of
graphs, individual peak and sustained leak subtracted values from
each fiber were first normalized with respect to the peak and
sustained current values at 1.5 min after the start of the trial for
this particular fiber. Then graphs showing baseline current
amplitude change during application and after washout of drugs
were made from the normalized data.
Results
FLP-Induced Contractions Require Extracellular Ca2+
We have previously reported that flatworm FMRFamide-like
peptides (FLPs) induce concentration-dependent contraction of
individual, dispersed schistosome muscle fibers, and that contract-
ed fibers relax with the cessation of FLP application [9,10]
(Figure 1). In order to investigate the source of the Ca2+ utilized in
Neuropeptides and Calcium Currents in Schistosomes
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the FLP-induced contractions, we attempted to induce those
contractions in varied extracellular Ca2+ conditions. In the
contraction assay, the individual muscle fibers are bathing in a
modified Dulbecco’s Modified Eagle Medium (DMEM) that
contains 4.1 mM Ca2+; the fibers are then perifused with the test
compounds dissolved in the same modified DMEM. When Ca2+ is
simply omitted from those media producing nominally Ca2+-free
media, the percentage of muscle fibers contracting in response to
FLPs drops from 7462% to 1564%, and when 10 mM EGTA is
added, FLP-induced contractions are completely abolished
(Figure 2).
These fibers do contain sufficient intracellular stores of Ca2+ to
support contraction. For example, under these same conditions in
which extracellular Ca2+ is taken away, caffeine can elicit
contraction via a ryanodine-sensitive intracellular store [18]. Since
YIRFamide does not elicit contractions under the same conditions,
it demonstrates that the FLP contraction does not utilize this
intracellular store, and reinforces the conclusion that the FLP-
induced contractions depend on an influx of extracellular Ca2+
(Figure 2). Together, these results show that the FLP-induced
contractions require extracellular Ca2+, even though there are
stores of intracellular Ca2+ sufficient to support contraction.
FLP-Induced Contractions Utilize Voltage-Operated
Calcium Channels
Next, we explored the conduit of Ca2+ entry. We have
previously reported that depolarization-induced contractions of
these same fibers are dependent on the presence of extracellular
Ca2+ and that those contractions use voltage-operated Ca2+
channels (VOCCs) [19], because some classical VOCC inhibitors
can block them. So, our first hypothesis was that the FLP-induced
contractions were also employing VOCCs present in the
sarcolemma. To test that hypothesis, we tested the ability of a
panel of VOCC blockers to block the FLP-induced contractions.
The FLP-induced contractions are blocked by relatively high
concentrations of some VOCC inhibitors, just as are the
depolarization-induced contractions (Figure 3). The dihydropyr-
idine nicardipine is the most potent blocker of the YIRFamide-
induced contractions, and it was previously shown to be the most
potent blocker of depolarization-induced contractions of the same
fibers [19]. Verapamil and methoxyverapamil (D-600) are both
effective blockers of the FLP-induced contractions, but they
require relatively high concentrations; control contractions were
reduced from 7262% to 1663% in 100 mM verapamil, and
1463% in 100 mM methoxyverapamil. The benzothiazipine
diltiazem was ineffective even at 100 mM; it was likewise quite
ineffective at blocking the depolarization-induced contractions at
this concentration.
These pharmacological data are somewhat equivocal in that
fairly high concentrations of the VOCC blockers are required for
inhibition of the contractions. This is not uncommon when
applying vertebrate pharmacological tools to these very early-
diverging invertebrates. For example, in two different jellyfish
preparations, very high concentrations of dihydropyridines and
phenyalkylamines were needed to block VOCCs [20,21].
However, the similarity of the rank order and potency of various
blockers on contractions elicited by depolarization and those
elicited by FLPs suggest that the pathway of Ca2+ entry for both
are the same, supporting the hypothesis and implicating VOCCs
in FLP-induced Ca2+ entry.
Voltage-Operated Ca2+ Currents in Schistosome Muscle
Our next hypothesis was that the FLPs are in some way
activating or enhancing the VOCCs in the sarcolemma. In order
to test this hypothesis, we first had to develop an approach to
measuring the VOCC currents of schistosome muscle fibers and
their modulation by exogenous modulators (such as VOCC
blockers or FLPs). Although we have measured VOCC currents in
these fibers previously using whole-cell patch-clamp techniques
[19], pharmacological assessments have been difficult, as the
currents are quite small and it is hard to distinguish a
pharmacological effect from the somewhat variable but very rapid
rundown.
Figure 2. The FMRFamide-like peptide (FLP)-induced contrac-
tions are dependent on the presence of extracellular Ca2+. In
normal extracellular medium containing 4.1 mM Ca2+, the muscle fibers
contract in response to exposure to the flatworm FLP YIRFamide,
depolarization with elevated extracellular K+ or caffeine. If the
extracellular Ca2+ is omitted, the FLP- and the depolarization-induced
contractions are significantly diminished; if 0.5 mM EGTA is included,
both are completely blocked. In contrast, caffeine-induced contractions
are not nearly as affected by the exclusion of extracellular Ca2+. Each
data point is the mean 6 SEM of % muscle fibers contracting, with n$5
for each point. Each treatment is compared to control, **P,0.01,
***P,0.005.
doi:10.1371/journal.pntd.0000790.g002
Figure 3. The FMRFamide-like peptide (FLP)-induced contrac-
tions are sensitive to classical voltage-operated Ca2+ channel
(VOCC) blockers. Although it required relatively high concentrations,
the FLP-induced contractions were significantly blocked by the
dihydropyridine nicardipine, as well as the phenylalkylamines verapamil
and methoxyverpamil, but not by the benzothiazipine diltiazem. The
potency and the rank order of efficacy of these VOCC blockers is the
same as have been reported previously for the blockade of
depolarization-induced contractions: nicardipine . verapamil <
methoxyverapamil ... diltiazem. The drugs were added 15 min
before testing with 1 mM YIRFamide. Data points represent the mean 6
SEM of % muscle fibers contracting, with n$5 for each point. **P,0.01,
***P,0.005.
doi:10.1371/journal.pntd.0000790.g003
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Amplifying the inward currents by providing additional
charge carrier. In order to better resolve the inward currents,
we tested a number of different extracellular bathing media. In the
standard extracellular bathing medium which contained 2.0 mM
Ca2+, inward currents were detectable, but usually too small to
lend themselves to ongoing study. Increasing the extracellular
Ca2+ as high as 10 mM amplified the inward currents, but also
dramatically changed the appearance of the fibers, causing a high
percentage of them to contract which made it difficult to find a
sufficient number of relaxed fibers from which to record. When
the extracellular bathing medium was supplemented with Ba2+,
the currents were also amplified, but the fibers did not contract.
The inward currents were most consistently recorded when the
2.0 mM Ca2+ normally present in the extracellular medium was
supplemented with 15 mM Ba2+. This proved successful in
enhancing the amount of available charge carrier without
producing dramatic untoward effects on the isolated muscle fibers.
A protocol for managing rapid rundown. We found that
the inward currents of these contractile schistosome muscle fibers
run down rapidly (Figure 4), as we have noted earlier [19] and as
has been reported for a number of VOCC currents in nerve and
muscle from other animals [22,23,24,25]. After we obtained
whole-cell access by disrupting the membrane under the pipet via
suction, the first minute was characterized by an increase in the
inward current, presumably attributable to reaching some
equilibrium between the intracellular solution in the pipet and
the contents of the cell. After seeing a peak inward current
somewhere near 1.5 min, there was a relatively stable current for
the next 2 to 3 min, followed by a steady decline in current
amplitude. For most muscle fibers, the inward current was less
than 20% of maximum within 8 min of whole-cell access.
Therefore, the window in which we could measure exogenous-
ly-induced increases or decreases in current was, at best, limited to
a time period between 1.5 min and 8 min after whole-cell access;
better was to restrict pharmacological examination to between
1.5 min and 4.5 min. We settled on a protocol in which exogenous
agents were perifused onto the voltage-clamped fibers between 2.0
and 4.5 min after whole-cell access, and experimental fibers were
always compared to control-perifused fibers in order to further
control for rundown.
Pharmacology of Voltage-Operated Calcium Channels in
Schistosome Muscle
Both the peak and the sustained inward currents are inhibited
by verapamil (Figure 5), the phenyalkylamine that also inhibited
contractions elicited by FLPs and depolarization. Within 30 sec
of application, 10 mM verapamil decreased the sustained current
to 4865% of maximum as compared to controls which showed
no significant decrement over the same time (9668%). At
100 mM verapamil the sustained current was decreased to
2063%. The peak inward current was also inhibited by
verapamil, but not as potently; the control peak current was
9066% of the maximum, while it was decreased to 6565% at
10 mM verapamil and 4764% at 100 mM. Verpamil’s inhibition
was reversible.
Unfortunately, it was not possible to test the entire panel of
VOCC blockers on the inward currents, because the dihydropyr-
idines precipitated in the extracellular bathing medium containing
high concentrations of divalent cations. Even at 10 mM,
nicardipine and nifedipine both formed visible precipitate in the
bathing medium with 15 mM Ba2+ and 2.0 mM Ca2+.
Flatworm FLPs Enhance the Inward Currents in
Schistosome Muscle
Using the same protocols, the flatworm FLP YIRFamide
significantly potentiates the inward currents (Figure 6). Within
30 sec after perifusion of the fibers with bathing medium
containing 1 mM YIRFamide, the sustained and peak inward
currents were both significantly enhanced compared to those
perifused with bathing medium alone. Whereas the control fibers
had rundown to 9066% of their maximum value, the inward
currents of the YIRFamide perifused fibers were 180621%
(sustained) and 190622% (peak) of their pre-treatment maximum
at the same time point.
Figure 4. Voltage-gated inward currents occur in schistosome muscle fibers, but they rapidly rundown. (A) An inward current is evoked
by a 200 ms depolarizing step to +20 mV from a holding potential of -70 mV in the presence of 2 mM extracellular Ca2+ and 15 mM extracellular
Ba2+. The dashed line represents the baseline current level, the horizontal bars show the times from which the peak and sustained current values
were derived, and the vertical scale bar is 20 pA. (B) The inward current runs down with time. On average, currents reached peak amplitude 1.5
minutes after the start of the trial and maintained an approximate steady level for the next 3-6 min followed by steady decline in amplitude. This
graph shows that peak and sustained current amplitudes for the same muscle fiber depicted in (A).
doi:10.1371/journal.pntd.0000790.g004
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The current potentiation was both transient and reversible. The
fibers were perifused with the FLP for 2.5 min, and the most
dramatic increases in the inward current amplitude were always
seen immediately after exposure to the peptide. Even during the
YIRFamide perifusion, the potentiation decreased toward control
values over time, although they remained greater throughout.
When the perifusion was shifted back to extracellular recording
medium alone, the currents quickly returned to control levels.
In order to test the interaction between verapamil’s inhibition
and YIRFamide’s stimulation of the VOCCs, we co-applied
both simultaneously (Figure 7). The co-application resulted in
VOCC currents that were neither as inhibited as verapamil
treated currents, nor were they as enhanced as YIRFamide
treated currents. With the co-application of 100 mM verapamil
and 1 mM YIRFamide, the current most closely resembled
control current.
Figure 5. The phenylalkylamine voltage-operated Ca2+ channel blocker verapamil reversibly inhibits the inward current. Both the (A)
sustained and (B) peak components of the inward current are significantly inhibited by 10 mM and 100 mM verapamil. For each fiber tested, in control
and test groups, peak and sustained currents were normalized to corresponding current values obtained at 1.5 minute after the start of the trial. Data
were plotted as mean 6 SEM. Seals and break-in were performed with cells constantly perifused with control solution. Cells remained under the
perifusion for the whole length of the trial. The shaded box indicates time points where cells were exposed to the drug-containing bathing solution
(for the test groups) or control solution itself (for the control group); (C) Representative traces of ICa/Ba activated by depolarizing S. mansoni muscle
fibers from Vh of -70 mV to +20 mV with a 200 ms test pulse in the absence or presence of verapamil (10 mM or 100 mM). The dotted line denotes
zero current level and the scale bar is 20 pA (traces from different fibers are scaled equally). The discontinuous time scale of the experiment is shown
above traces, and each of the depolarizing pulses is 200 ms.
doi:10.1371/journal.pntd.0000790.g005
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Examining the Biochemical Link Between YIRFamide and
VOCCs
There is a striking parallel between the physiological data here
and previous observations of protein kinase C (PKC)-mediated
contractions of schistosome musculature, as induced by phorbol
esters on whole male worms. PKC stimulation produces
contraction of the muscle in a manner that depends on
extracellular Ca2+ and is sensitive to nicardipine, leading the
investigators to conclude that ‘‘activation of PKC in schistosomes
with phorbol esters leads to muscle contracture by enhancing
sarcolemmal Ca2+ channel activity’’ [26].
Other research suggests that most FLPs exert their effects
through G protein-coupled receptors (GPCRs). Specifically
germane to this model, a GPCR has been demonstrated to be a
receptor for GYIRFamide in the flatworm Girardia tigrina [27].
Physiological data related to FLP contractions of flatworm muscle
also implicate GPCRs in a number of species [7,14,17]. Working
with Fasciola hepatica, Graham et al. found that GYIRFamide and
other FLPs induced increased frequency and amplitude of muscle
strip contractions [14]. They also found that these FLP-induced
contractions involved G-protein mediated signaling and were
mimicked by phorbol esters [17]. Chelerythrine chloride (10 mM)
Figure 6. YIRFamide enhances whole cell voltage-gated ICa/Ba in isolated S. mansoni muscle fibers. (A) Both peak and sustained
ICa/Ba increased in amplitude upon treatment with 1 mM YIRFamide. YIRFamide was applied as indicated with the shaded box. Data were
normalized as described in Figure 4 and plotted as mean 6 SEM. (B) Representative traces of ICa/Ba before, during and after application of the
peptide show the enhancement of the current and the washout of the effect after the cessation of application. The dotted line denotes zero
current level and the scale bar is 20 pA. The discontinuous time scale of the experiment is shown above traces, and each of the depolarizing
pulses is 200 ms.
doi:10.1371/journal.pntd.0000790.g006
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blocked the FLP-induced contractions of Fasciola, pointing to a
PKC-dependent pathway.
Together, these data lead to a hypothesis that a PKC pathway is
involved in FLP-induced contractions of schistosome muscle, and
this hypothesis is granted further credibility because GPCRs are
known to enhance VOCC currents via a PKC pathway in some
other systems. For example, metabotropic glutamate receptors
have been shown to stimulate VOCCs from the CaV2 family (N-
and R-type calcium channels) through a protein kinase C pathway
that depends on an interaction with the calcium channel b sub-
units [28].
We therefore tested a few PKC inhibitors to see if that pathway
could be linked to the FLP-induced contractions. All of the PKC
inhibitors we tested, calphostin C, RO 31–8220 and chelerythrine
chloride, produced a concentration dependent block of contrac-
tions elicited by 1 mM YIRFamide (Figure 8). Calphostin C was
the most potent, blocking with an IC50 = 61 nM, well within the
concentrations at which it is considered specific for PKC inhibition
[29]. Chelerythrine chloride specifically inhibits rat brain PKC at
0.7 mM, and also inhibited the neuropeptide contractions with an
IC50 of 0.66 mM, well within the concentration typically
considered specific for PKC inhibition in other systems [30].
The bisindolylmaleimide RO 31–8220 also blocked these
contractions, but at relatively high concentrations (IC50 =
1.54 mM) which might be attributable to other, less specific effects
of the compound.
Discussion
Our goal was to elucidate the mechanism of FLP-induced
contractions of S. mansoni muscle fibers. We found the FLP-
induced contractions very much resemble depolarization-induced
contractions both physiologically and pharmacologically. Specif-
ically, the FLP-induced contractions utilize extracellular Ca2+ and
the pharmacological profile implicates voltage-operated Ca2+
channels (VOCCs) as the conduit for entry into the muscle fibers.
After developing a protocol to reliably measure inward VOCC
currents and deal with their rapid rundown, we tested the effects of
FLPs on these currents. We found that the VOCC currents were
sensitive to the same blockers that inhibited the FLP-induced
Figure 7. YIRFamide-mediated increase of ICa/Ba in S. mansoni isolated muscle fibers is reduced during treatment with the Ca
2+
channel blocker verapamil. Verapamil reduced the enhancement of ICa/Ba produced by YIRFamide, for both the (A) sustained and (B) peak
currents. In each graph, data are compared showing currents under control conditions, the inhibition produced by 100 mM verapamil, the
enhancement produced by 1 mM YIRFamide, and the co-application of both verapamil and YIRFamide, which in both cases most closely resembles
the control currents. (C) Representative traces of ICa/Ba before, during and after treatment with 100 mM verapamil and 1 mM YIRFamide show currents
that are effected by the co-application, but are intermediate to either agent applied alone. Data are plotted as mean 6 SEM. Both verapamil and
YIRFamide were dissolved in extracellular recording solution and delivered simultaneously during the time span indicated by a shaded box. The
dotted line denotes zero current level and the scale bar is 20 pA. The discontinuous time scale of the experiment is shown above traces, and each of
the depolarizing pulses is 200 ms.
doi:10.1371/journal.pntd.0000790.g007
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contractions. Then, we found that the application of FLPs
enhance the inward VOCC currents, almost doubling their size.
Physiological data related to FLP contractions of flatworm
muscle implicate GPCRs in a number of species [7,14,17]. There
are a few well-documented cases of GPCRs linked to VOCC
modulation, with many acting through a PKC pathway [28]. We
found that the FLP-induced contractions in schistosome muscle
are also dependent on a PKC pathway.
PKC has been implicated in muscle contraction in flatworms
and even in neuropeptide-induced contractions. PKC activators
(phorbol esters) have potent stimulatory effects on flatworm
muscle, including schistosomes [17,26]. Data here link these
FLP-induced contractions to a PKC-dependent pathway and,
therefore, the associated stimulation of VOCCs.
Neuronal VOCCs have been shown to be a target for
enhancement by PKC [31,32,33,34]. Heterologously expressed
rat brain VOCCs can be stimulated by PKC activation, producing
current increases of 130%–150% over controls. The PKC-
mediated enhancement of the currents required co-expression of
the non-conducting VOCC b subunits, and the PKC modulation
involves a direct interaction with those b sub-units [28].
Interestingly, modulation of the interaction between schisto-
some calcium channel a and b subunits looks to be a target of the
preeminent antischistosomal drug, praziquantel. Praziquantel
interacts with structurally unusual schistosome VOCC b subunits
to enhance current conducted through alpha subunits [35,36].
This work elucidates some of the fundamental biology
underlying schistosome neuromuscular biology. Specifically, that
FLP neuromuscular excitation involves a PKC-dependent path-
way leading to enhancement of Ca2+ influx through sarcolemmal
VOCCs. Understanding the neuromuscular physiology of these
worms is tantamount to understanding what has proven to be the
most fertile field from which to harvest anti-schistosomal drugs.
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